← Back to all clusters

Cluster 309

7 diseases · 16 shared-gene connections
7 Diseases
2 Unique genes
0.437 Avg. similarity score
Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies Most-connected disease (6 links)
Log in to save this analysis

Save This Analysis

Disease Searched: Short stature, palatal anomalies, congenital heart disease, and skeletal malformations Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
BMP2 6 / 7 20p12.3 microdeletion syndrome, Hfe hemochromatosis, modifier of, Right ventricle hypoplasia, Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies and 2 more
SCUBE3 2 / 7 Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies, Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Transcriptional regulation by RUNX2 Reactome 1 / 12 500× 2.00e-3 1.90e-2 ✓ sig.
Signaling by BMP Reactome 1 / 28 214× 4.66e-3 3.48e-2 ✓ sig.
Molecules associated with elastic fibres Reactome 1 / 38 158× 6.32e-3 4.25e-2 ✓ sig.
Basal cell carcinoma KEGG 1 / 63 95.3× 1.05e-2 5.84e-2
Degradation of the extracellular matrix Reactome 1 / 70 85.8× 1.16e-2 6.22e-2
TGF-beta signaling pathway KEGG 1 / 108 55.6× 1.79e-2 8.04e-2
Hippo signaling pathway KEGG 1 / 157 38.2× 2.60e-2 9.97e-2
Cytokine-cytokine receptor interaction KEGG 1 / 298 20.2× 4.90e-2 1.43e-1
Pathways in cancer KEGG 1 / 533 11.3× 8.68e-2 1.99e-1

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
positive regulation of osteoblast differentiation GO:0045669 2 / 78 240× 1.72e-5 8.24e-4 ✓ sig.
negative regulation of calcium-independent cell-cell adhesion GO:0051042 1 / 1 9,344× 1.07e-4 3.25e-3 ✓ sig.
endodermal-mesodermal cell signaling GO:0003133 1 / 2 4,672× 2.14e-4 5.31e-3 ✓ sig.
cardiac atrium formation GO:0003210 1 / 2 4,672× 2.14e-4 5.31e-3 ✓ sig.
cardiocyte differentiation GO:0035051 1 / 2 4,672× 2.14e-4 5.31e-3 ✓ sig.
mesenchymal cell proliferation involved in ureteric bud development GO:0072138 1 / 2 4,672× 2.14e-4 5.31e-3 ✓ sig.
regulation of cardiac muscle cell differentiation GO:2000725 1 / 2 4,672× 2.14e-4 5.31e-3 ✓ sig.
positive regulation of extracellular matrix constituent secretion GO:0003331 1 / 3 3,115× 3.21e-4 7.04e-3 ✓ sig.
positive regulation of phosphatase activity GO:0010922 1 / 3 3,115× 3.21e-4 7.04e-3 ✓ sig.
embryonic heart tube anterior/posterior pattern specification GO:0035054 1 / 3 3,115× 3.21e-4 7.04e-3 ✓ sig.
corticotropin hormone secreting cell differentiation GO:0060128 1 / 3 3,115× 3.21e-4 7.04e-3 ✓ sig.
positive regulation of bone mineralization involved in bone maturation GO:1900159 1 / 3 3,115× 3.21e-4 7.04e-3 ✓ sig.
negative regulation of aldosterone biosynthetic process GO:0032348 1 / 4 2,336× 4.28e-4 8.53e-3 ✓ sig.
cardiac jelly development GO:1905072 1 / 4 2,336× 4.28e-4 8.53e-3 ✓ sig.
atrioventricular canal morphogenesis GO:1905222 1 / 4 2,336× 4.28e-4 8.53e-3 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
20p12.3 microdeletion syndrome Right ventricle hypoplasia 0.500 1 6.46e-5 1.98e-4 ✓ sig.
20p12.3 microdeletion syndrome Short stature, palatal anomalies, congenital heart disease, and skeletal malformations 0.500 1 6.46e-5 1.98e-4 ✓ sig.
20p12.3 microdeletion syndrome Hfe hemochromatosis, modifier of 0.500 1 6.46e-5 1.98e-4 ✓ sig.
20p12.3 microdeletion syndrome Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 0.500 1 6.46e-5 1.98e-4 ✓ sig.
Hfe hemochromatosis, modifier of Right ventricle hypoplasia 0.500 1 6.46e-5 1.98e-4 ✓ sig.
Hfe hemochromatosis, modifier of Short stature, palatal anomalies, congenital heart disease, and skeletal malformations 0.500 1 6.46e-5 1.98e-4 ✓ sig.
Hfe hemochromatosis, modifier of Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 0.500 1 6.46e-5 1.98e-4 ✓ sig.
Right ventricle hypoplasia Short stature, palatal anomalies, congenital heart disease, and skeletal malformations 0.500 1 6.46e-5 1.98e-4 ✓ sig.
Right ventricle hypoplasia Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 0.500 1 6.46e-5 1.98e-4 ✓ sig.
Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 Short stature, palatal anomalies, congenital heart disease, and skeletal malformations 0.500 1 6.46e-5 1.98e-4 ✓ sig.
20p12.3 microdeletion syndrome Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 0.333 1 1.29e-4 3.27e-4 ✓ sig.
Hfe hemochromatosis, modifier of Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 0.333 1 1.29e-4 3.27e-4 ✓ sig.
Right ventricle hypoplasia Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 0.333 1 1.29e-4 3.27e-4 ✓ sig.
Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies Short stature, palatal anomalies, congenital heart disease, and skeletal malformations 0.333 1 1.29e-4 3.27e-4 ✓ sig.
Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 0.333 1 1.29e-4 3.27e-4 ✓ sig.
Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 0.333 1 1.29e-4 3.27e-4 ✓ sig.